DOCSLIB.ORG

ASMS Directory of Members

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

ASMS Directory of Members DAVID AASERUD FRED P ABRAMSON JEANETTE ADAMS DEPARTMENT OF CHEMISTRY DEPARTMENT OF PHARMACOLOGY DEPARTMENT OF CHEMISTRY BOX 342, BAKER LAB GEORGE WASHINGTON UNIVERSITY EMORY UNIVERSITY CORNELL UNIVERSITY 2300 EYE STREET NORTHWEST ATLANTA, GA30322 ITHACA, NY 14853 WASHINGTON , DC 20037 Phone: 404 7276522 Phone: 6072553731 Phone: 2029942946 Fax: 404 7276586 Fax: 607255-7880 Fax: 202 994 2870 [email protected] LARRY ABBEY ANDREW ACHEAMPONG NATHAN ADAMS TRIANGLE LABS OF ATLANTA, INC ALLERGAN PHARMACEUTICALS DEPARTMENT OF CHEMISTRY \703 WEBB DR, SUITE C 2525 DUPONT DRIVE UNIVERSITY OF NORTHERN lOWA NORCROSS , GA 30093 IRVINE, CA 92715 CEDAR FALLS, IA 50614-0423 Phone: 4044466393 Phone: 714 724 4950 Phone: 3192732435 Fax: 4044466392 Fax: 714 724 5850 [email protected] FRANK S ABBOTT BRADLEY L ACKERMANN NIGEL G ADAMS FACULTY OF PHARMACEUTICAL SCI MARION MERRELL DOW, INC DEPARTMENT OF CHEMISTRY UNIVERSITY OF BRITISH COLUMBIA 2110 E GALBRAITH ROAD UNIVERSITY OF GEORGIA 2\46 EAST MALL BLDG. 26-1 ATHENS, GA 30602 VANCOUVER, BC, V6T \23 CINCINNATI, OH 45215-6300 Phone : 4045423722 CANADA Phone: 513 948 6081 Fax: 4045429454 Phone: 604822 2566 Fax: 513 9487360 [email protected] Fax: 6048223035 [email protected]!vID.COM ROBERT A ADAMS MAGED ABDELRAHIM MICHAELRACKERMANN ARLSINC. WALTER REED ARMY MEDICAL CTR FISONS INSTRUMENTS 3480 TANBARK CT. NE DEPT OF CLINICAL INVESTIGATION 55 CHERRY HILL DRIVE ATLANTA, GA30319 WASHINGTON, DC 20307 BEVERLY, MA 01915 Phone: 4042554817 Phone: 202 782 7612 Phone: 508524 1000 Fax: 4048479892 Fax: 202 7823286 RAADAMS@NETCOMCOM M.J. ACKLAND IHAB ABDELREHIM UPJOHNLTD SHERRI-SUE ADAMS CHEMISTRY DEPARTMENT FLEMING WAY, CRAWLEY CHEMISTRY DEPARTMENT UNIVERSITY OF CALIFORNIA SUSSEX RH I0 2LZ, MICHIGAN STATE UNIVERSITY DAVIS, CA 956\6 UNITED KINGDOM EAST LANSING, MI 48824 Phone : 916 7529076 Phone: 0403582336 Phone: 517 355 9715 Fax: 916 7528995 Fax: 5173551793 [email protected] ROBERT V ACUFF SURGERY DEPT-PO BOX 70,575 WILLIAM ADAMS WILLIAM H ABERTH JOHNSON CITY, TN 37614-0575 FIRMENICH, INC ANTEK Phone: 6159296257 PRINCETON-PLAINSBORO ROAD 3\46 MANCHESTER COURT Fax: 6159296459 PLAINSBORO, NJ 08536 PALO ALTO, CA 94303 [email protected]·TENN-ST.EDU Phone : 6094521000 Phone: 4158562412 Fax: 609452 7857 Fax: 4158562412 DAVID C ADAMS ICI CANADA, INC TERRI ADDONA STACY R. ABNER SHERIDAN PARK RESEARCH CENTER UNIVERSITY OF VIRGINIA \52\ B STREET, APT. 2 MISSISSAUGA, ONT, L5K 2L3 DEPARTMENT OF CHEMISTRY LINCOLN, NE 68502 CANADA MCCORMICK ROAD Phone: 4024769122 Phone: 9058237160 CHARLOTTESVILLE, VA 2290 I [email protected] Fax: 905823 0044 Phone: 804924 7994 Fax: 8049822781 CRAIG ABOLIN FADAMS [email protected] SANDOZ RESEARCH INSTITUTE DEPARTMENT OF CHEMISTRY 59 ROUTE \0 UNIVERSITY OF ANTWERP ONIGBINDE ADEBAYO EAST HANOVER, NJ 07936·\0 II UNIVERSITEITPSLEIN I, WILRIJK DEPARTMENT OF CHEMISTRY Phone: 2015038631 2610 ANTWERPEN, UNIVERSITY OF DELAWARE Fax: 201 5038487 BELGIUM NEWARK , DE 19716 [email protected] Phone: 3238202005 Phone : 3028314514 Fax: 3238202024 Fax: 302831 6553 LINDA D ABRAMS PHARMACO GREG ADAMS SUBHODAYA ADURU 2240 DABNEY ROAD 1461 17TH AVENUE 284 MARlORI AVENUE RICHMOND , VA 23230 SAN FRANCISCO, CA 94122 THOUSAND OAKS, CA 91320 Phone: 8043591900 Phone: 4156659377 Phone: 805 499 0754 Fax: 8043531860 Fax: 805499 0754 © 1995 American Society for Mass Spectrometry 1044-0305/95/$9.50 ssor 1044-0305(95)00522-F 672 ASMS DIRECTORY OF MEMBERS, 1995 BEAT AEBI SATOKO AKASUI LOUIS ALEXANDER IRM, UNIVERSITAT BERN BIOMOLECULAR CHARACTERIZATION 23 BAILEY DRIVE BUHLSTR.20 RIKEN LILBURN, GA 30247 CH-3012, BERN, 2-1 HIROSAWA. WAKO-SHI Phon e: 4049234953 SWITZERLAND SAITAlvlA 351-01 , JAPAN MICHAEL S ALEXANDER NOUBAR AFEYAN Phone: 8/48462/// SANDOZ PHARMACEUTICALS PERSEPTIVE BIOSYSTEMS, INC. Fax: 81484624704 59 ROUTE 10, BLDG 405 /2 500 OLD CONNECTICUT PA11-1 EAST HANOVER, NJ 07936 FRAMlNGHAM,lvlAOl701 ADNAN A AL-HAJ.n Phone : 201 5038094 Phone: 8008995858 SAUDI ARAlvlCO Fax: 201 503 63/8 Fax: 508383 7885 2250 lvlONROE /I I89 SANTA CLARA. CA 95050 NELSON E ALEXANDER SUNIA AFZAAL Phone: 4/5 7255355 AMELUND ENTERPRISE BRm~ER INSTRUMENTS Fax: 4/5 723 8489 120 I MOTTER AVENUE 19 FORTUNE DRIVE FREDERICK, MD 21701-4544 BILLERICA, MA 0 I82 I ABDULAZIZ H AL-HUMYDI Phone : 301 6639085 Phone: 5086679580 SABIC R&D Fax: 5086675993 PO BOX 42503 EDALFORD [email protected] RIYADH 11551, ALFORD CONSULTING, INC. SAUDI ARABIA 3524 HUGHES ROAD SURESH K AGGARWAL Phone: 966l.f985555 LOUISVILLE. KY 40207-4332 FUEL CHEMISTRY DIVISION Fa~: 966/4980938 Phone : 5028935558 BHABHA ATOMIC RESEARCH CENTER Fax: 5028935558 TROMAY MOHAMMED A. AL-TUFAIL BOMBAY 400085, KING FAISAL SPEC HOSP & RES. DAVID ALKALAY INDIA PO BOX 3354 27 REVERERD Phone : 0225565694 PATHOLOGY MBC 10 ARDSLEY, NY 10502-1219 Fax: 0225560750 RIYADH I 1211. Phone : 9/46931975 SAUDI ARABIA GEORGE AGNES Phone: 966/ 464 7272 ALEXANDER R ALLAN DEPARTMENT OF CHEMISTRY Fax: 9661 .f.f24280 2 GORE END VILLAS SIMON FRASER UNIVERSITY GORE END BURNABY N. GEORGE ALAMEDDIN NEWBURY BRITISH COLUMBIA, V5A IS6 UNIVERSln' OF FLORIDA BERKS RGI5 OPJ, CANADA DEPARTt\·IENT OF CHEMISTRY UNITED KINGDOM PO BOX I 17200 Phone : 0734814/00 DOUGLAS AGNEW GAINESVILLE, FL32611-2046 Fax: 44 734819 733 HEWLETT-PACKARD Phone: 9043920536 1601 CALIFORNIA AVENUE Fax: 904393 0872 ANTHONY ALLEGRINO PALO ALTO, CA 94304 [email protected] AKZO CHEMICAL Phone : 4158577133 I LIVINGSTONE AVENUE Fax : 4/58528011 ARMANDO ALCARAZ DOBBS FERRY, NY 10522 LAWRENCE LIVERMORE NAT'L LAB Phone: 9/4 674 5144 MARTIN AHNOFF PO BOX 808, L-371 Fax: 9/4 6935780 ASTRA MASSLE AB 7000 EAST AVENUE S-43 I 83 MOLNDAL, LIVERMORE, CA 94550 MARK ALLEN SWEDEN Phone: 4/54236889 PERKIN-ELMERISCIEX Phone : 46317761352 Fax: 5/04239014 55 GLEN CAMERON ROAD Fax: 46317763760 THORNHILL,ONT, L3T IP2 ANTHONYJALEXANDER CANADA ,JJUAI BRISTOL MYERS SQUIBB Phone: 4/688/4646 US TOBACCO COMPANY PHARMACEUTICAL RESEARCH INST Fax: 41688/9832 RESEARCH & DEVELOPMENT PO BOX 4755 ALLEN@SC1E¥.COM 800 HARRISON STREET SYRACUSE, NY 13221-4755 NASHVILLE, TN 37203 Phone: 3154322756 RAYMOND HALLEN Phone : 6152712512 ALLEN SCIENTIFIC GLASS INC Fax: 615 2712192 DESIREE C ALEXANDER 1752 55TH ST THE BIRMINGHAM WATERWORKS BOULDER, CO 80301-2702 MUHAMMAD SALEH AJAZ 3600 IST AVENUE NORTH Phone: 3034422141 DEPARTMENT OF CHEMISTRY BIRMINGHAM, AL 35222 Fax: 3034422260 UNIVERSITY OF NEBRASKA Phone: 205251 3261 LINCOLN, NE 68588-0304 TODD M. ALLEN Phone : 402472 3507 .JERRY W ALEXANDER DEPARTMENT OF CHEMISTRY Fax: 402472 942 CA DEPT OF FOOD & AGRICULTURE UNIVERSITY OF CALIFORNIA 3292 MEADOWVIEW ROAD DAVIS, CA 956 I6 SACRAMENTO, CA 95832 Phone: 9167527084 Phone: 9/62621547 Fax: 9167528995 Fax: 9162621542 [email protected] ASMS DIRECTORY OF MEMBERS, 1995 673 .JOHN ALLISON JON AMSTER GREGORY J. ANDERSON CHEMISTRY DEPARTMENT DEPARTMENT OF CHEMISTRY JAMES RIVER CORPORATION MICHIGAN STATE UNIVERSITY UNIVERSITY OF GEORGIA 1915 MARATHON AVENUE EAST LANSING, MI 48824 ATHENS, GA 30602-2556 P.O. BOX 899 Phone: 517 355 9715 Phone: 7065422001 NEENAH, WI 54957-0899 Fax: 517353 1793 Fax: 7065429454 Phone: 414 7298450 [email protected] Fax: 414 429 8023 GUNTER ALLMAIER INST FOR ANALYTICAL CHEMISTRY DANIEL S AMUNDSON J.L. ANDERSON UNIVERSITY OF VIENNA DEPARTMENT OF CHEMISTRY EXXON RESEARCH & ENGINEERING WAHRINGER STR. 38 MONTANA STATE UNIVERSITY 4500 BAYWAY DRIVE A-1090 VIENNA, BOZEMAN, MT 59717 BAYTOWN, TX 77522 AUSTRIA Phone: 469945412 Phone: 7134255128 Phone: 43313672416 YANAN Fax: 713 4252057 Fax: 433196312 DEPARTMENT OF CHEMISTRY UNIVERSITY OF OITAWA LAWRENCE ANDERSON ANDREW ALTMAN OITAWA, ONT., KIN 6N5 US FDA FISONS INSTRUMENTS CANADA 4 RESEARCH COURT, RM 314 3301 CADENCIASTREET Phone: 613 562 5800 ROCKVILLE, MD 20850 CARLSBAD, CA 92009 Fax: 613 562 5170 Phone: 3014271065 Phone: 6194366522 Fax: 619943 7032 JOSEPH ANACLETO MELISSA A ANDERSON SCIEX ANALYTICAL TOXICOLOGY ERWIN J ALVAREZ 55 GLEN CAMERON ROAD CORNELL UNIVERSITY DEPARTMENT OF CHEMISTRY THORNHlLL,ONT., DT IP2 927 WARREN DRIVE UNIVERSITY OF TEXAS CANADA ITHACA, NY 14850 AUSTIN, TX 78712-1167 Phone: 905881 4646 Phone: 6072533972 Phone: 5124710041 Fax: 905881 9832 Fax: 6072533973 Fax: 512471 0985 [email protected] BOBANACONE PAUL D. ANDERSON PERSEPTIVE BIOSYSTEMS 58900 CHERRY GROVE ROAD GUNVOR ALVELIUS 500 OLD CONNECTICUT PATH DOWAGIAC, MI 49047-9726 CLIN-RESEARCH CENTER FRAMINGHAM, MA 01701 Phone: 616 782 1254 NOVUM HUDDINGE HOSPITAL Phone: 8008995858 14186 HUDDINGE, Fax: 508383 7885 PHIL ANDERSON SWEDEN INDIANA UNIVERSITY Phone: 468 7465200 ROBERT J ANDEREGG GEOLOGY 541 Fax: 4687465210 GLAXO,INC BLOOMINGTON, IN 47404 5 MOORE DRIVE Phone: 812 855 5976 J DOUGLAS ALVES-SANTANA RES TRIANGLE PARK, NC 27709 Fax: 812855 7899 RW JOHNSON PHARM RES INST Phone: 9199413495 [email protected] ROUTE 202 SOUTH Fax: 9199413411 PO BOX 300 [email protected] SCOTT ANDERSON RARITAN, NJ 08869-0602 106 EAST 30TH STREET #205 Phone: 908 7044009 DAVE ANDERSON AUSTIN, TX 78705-3851 Fax: 908741612 KHEPRI PHARMACEUTICALS Phone: 512471 4992 260 LITTLEFIELD AVE. Fax: 512471 0985 FRANCISCO H.L. AMADO S. SAN FRANCISCO, CA 94080 :[email protected] UNIVERSITY AVEIRO Phone: 4157943503 DEPT. OF CHEMISTRY Fax: 415 7943599 SCOTT L ANDERSON 3800 AVEIRO, CHEMISTRY DEPARTMENT PORTUGAL DAVID J ANDERSON UNIVERSITY OF TEXAS Phone: US EPA WELCH HALL, 24TH & SPEEDWAY Fax: GLNPO AUSTIN, TX 78705 77 W JACKSON BOULEVARD Phone: 512471 4992 SONYA AMELKIN-GOLDSTEIN CHICAGO, IL 60604-3590 Fax: 5164710985 428 GAMBOCZ COURT Phone: 3123532015 MONMOUTH JUNCTION, NJ 08852 Fax: 3123532018
Recommended publications
  • Southern Planter: Devoted to Practical and Progressive Agriculture

    Southern Planter: Devoted to Practical and Progressive Agriculture

    : : : : Established 1840. THE Sixty-Fourth Year. Southern Planter A MONTHLY JOURNAL DEVOTED TO Practical and Progressive Agriculture, Horticulture, Trucking, Live Stock and the Fireside. OFFICE: 28 NORTH NINTH STREET, RICHMOND, VIRGINIA. THE SOUTHERN PLANTER PUBLISHING COMPANY, Proprietors. J. F. JACKSON, Editor sad General Manager. Vol. 64. MARCH, 1903. No. 3. CONTENTS. FARM MANAGEMENT LIVE STOCK AND DAIRY : Editorial— for the 153 Work Month Herefords at Anneneld, Clarke Co., Va 177 "All Flesh is Grass." 156 HerefordB'at Castalia, Albemarle Co., Va 177 High Culture or the Intensive System, as Applied Confining CowsiContinuously During Winter. 178 to the Culture of Corn. ...^ 157 A Green Crop All Summer—Corn and Cow-Peas.. 159 Bacon, and a " Bacon Breed." - 179 Grasses and Live Stock Husbandry—Bermuda Biltmore Berkshire Sale « ~ 180 160 GraBS The Brood Sow 181 The Difference in Resalts from Using a Balanced and an Unbalanced Fertilizer 161 Artichokes ^--•"MtABD: My Experience with SO 2, gif x Italian Grass Rye -«-JL ** ,. \aying Competition of Breeds 182 Improving Mountain! Land 163 Nitrate of Soda as.a Fertilizer for Tobacco Plant- Cost cf Producing a Broiler 182 Beds '. 164 Humus ~ 164 THE HORSE Enquirer's Column (Detail {Index, page 185)....'.... 166 Notes 183 TRUCKING, GARDEN 'ANDIORCHARD Editorial—Work for the Month 171 Notes on Varieties of Apples at the Agricultural MISCELLANEOUS Experiment Station, Blacksburg, Va „ 174 Brownlow's Good Roads Bill—A Practical and Garden and Orchard Notes _ 175 Conservative Measure „ 184 Work in the Strawberry.Patch 176 Editorial—Spraying Fruit Trees and Vegetable Publisher's Notes - 185 Crops 176 Editorial—San Jose Scale ~.
  • Correlation of Physicochemical Properties of Model Drugs and Aerosol Deposition

    Correlation of Physicochemical Properties of Model Drugs and Aerosol Deposition

    CORRELATION OF PHYSICOCHEMICAL PROPERTIES OF MODEL DRUGS AND AEROSOL DEPOSITION w ANA CATARINA MATOS DE OLIVEIRA A thesis submitted for the degree of Doctor of Philosophy Department of Pharmaceutics The School of Pharmacy, University of London 29-39 Brunswick Square London WC IN 1 AX, UK MARCH 2009 ProQuest Number: 10104755 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 10104755 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Plagiarism Statement This thesis describes research conducted in the School of Pharmacy, University of London between 2004 and 2008 under the supervision of Prof. Graham Buckton and Dr. Simon Gaisford. I certify that the research described is original and that any parts of the work that have been conducted by collaboration are clearly indicated. I also certify that I have written all the text herein and have clearly indicated by suitable citation any part of this dissertation that has already appeared in publication. Signature Date Abstract Dry powder inhalers (DPIs) are recognized devices for the administration of medicines to the lungs.
  • Brinkley, Chapter 10 Notes 1

    Brinkley, Chapter 10 Notes 1

    Brinkley, Chapter 10 Notes Population Trends Three trends characterized the American population between 1820-1840: 1. Population reached 17 million by Brinkley, 1840 2. African American population Chapter 10 increased more slowly than whites due to the abolition of the slave trade 3. Immigration from Ireland and Germany surged America's Economic Revolution Immigration and Urban Growth 1840-1860 Rise of Nativism Democrats eagerly welcomed immigrants Growth of cities accelerated dramatically between 1840-1860 Others viewed immigrants with suspicion and alarm. Argued immigrants were Major cities in the West rose: Pittsburgh, St. Louis, Cincinnati, Louisville racially inferior or corrupted politics by selling their votes. Protestants worried the Irish Catholics would increase the power of the Catholic Church. Immigrants moved to cities: New York City, Chicago, and Milwaukee Overwhelming majority of immigrants between 1840-1860 came from Secret societies formed to combat the "alien menace." Ireland and Germany The first was the Native American Party who wanted to ban Catholics from Most Irish became part of the unskilled white labor force. holding public office, enact more restrictive naturalization laws, and establish Largest group of Irish were young single women who worked in literacy tests to vote. The order adopted a strict code of secrecy and the group factories or in domestic service. became known as the "Know-Nothings" Germans usually arrived with some money and settled in the Northwest where they became farmers or small businessmen. Canal Age Impact of the Erie Canal Canals were increasingly built to connect other major sources of water. It was cheaper for western farmers to ship Financing canals fell upon the states.
  • Module 2.7.1 Summary of Biopharmaceutic Studies and Associated Analytical Methods

    Module 2.7.1 Summary of Biopharmaceutic Studies and Associated Analytical Methods

    CONFIDENTIAL 2.7.1 Summary of Biopharmaceutic Studies and Associated Analytical Methods Module 2.7.1 Summary of Biopharmaceutic Studies and Associated Analytical Methods Copyright 2012 ViiV Healthcare and the GlaxoSmithKline group of companies. All rights reserved. Unauthorized copying or use of this information is prohibited. 1 CONFIDENTIAL 2.7.1 Summary of Biopharmaceutic Studies and Associated Analytical Methods TABLE OF CONTENTS PAGE ABBREVIATIONS ...........................................................................................................3 1. BACKGROUND AND OVERVIEW ...........................................................................4 1.1. Conclusions ..................................................................................................4 1.2. Formulation Development.............................................................................5 1.3. In Vitro Dissolution Data .............................................................................10 1.3.1. Comparative of 2 x 25 mg Clinical Tablets and 1 x 50 mg Clinical Tablets, Phase III Formulation.........................................10 1.3.2. Comparison of Phase III Clinical Image and Commercial Image Tablets..............................................................................13 1.4. Analytical Methods......................................................................................17 1.4.1. Validation.....................................................................................17 1.4.2. Summary of Within Study Quality
  • 2017 WEEKLY BULLETIN DEPARTMENT of CHEMISTRY, NORTHWESTERN UNIVERSITY EVANSTON, ILLINOIS April 24, 2017

    2017 WEEKLY BULLETIN DEPARTMENT of CHEMISTRY, NORTHWESTERN UNIVERSITY EVANSTON, ILLINOIS April 24, 2017

    2017 WEEKLY BULLETIN DEPARTMENT OF CHEMISTRY, NORTHWESTERN UNIVERSITY EVANSTON, ILLINOIS April 24, 2017 For full schedule, including Center events, please see the Department Calendar: http://www.chemistry.northwestern.edu/events/calendar.html Tuesday April 25th: Faculty Lunch Seminar: Neil Kelleher Tech K140 12:00 – 1:00pm Friday April 28th: Chemistry Department Colloquium: Stacey F. Bent, Stanford University Tech LR3 4:00-5:00pm BIP BIP meets every Friday 10-11:00am in Tech K140 Arrivals We did not have any new arrivals Announcements 10th Annual ANSER Solar Energy Symposium April 27-28, 2017: The Argonne-Northwestern Solar Energy Research Center (ANSER) and the Institute for Sustainability and Energy at Northwestern (ISEN) are delighted to host the 10th annual ANSER Solar Energy Symposium – “Solar Electricity.” As our understanding of the impact of climate change continues to grow, so too does the global trend towards a clean-energy economy. The last two years have seen organic photovoltaics reach efficiencies of 11.5 percent, quantum dot solar cells reach efficiencies of 11.3 percent and perovskite solar cells continue their meteoric rise to efficiencies of 22.1 percent, paving the way for continually decreasing photovoltaic costs. This encouraging march toward a cleaner power sector cannot be ignored, and is built on the foundation of innovative research being carried out at collaborative scientific hubs such as the ANSER Center. The thematic focus of this year’s Symposium is “Solar Electricity,” and we are honored to host a star-studded lineup of speakers. These photovoltaic leaders will present life-cycle analyses, report the current state-of- the-art, outline challenges ahead, and propose new ideas to pursue in this rapidly growing field of solar photovoltaic research.
  • 05/01/02 Louisiana Medicaid Management

    05/01/02 Louisiana Medicaid Management

    APPENDIX C 05/01/02 LOUISIANA MEDICAID MANAGEMENT INFORMATION SYSTEM PAGE 1 DEPT OF HEALTH AND HOSPITALS - BUREAU OF HEALTH SERVICES FINANCING LOUISIANA MEDICAID PHARMACY BENEFITS MANAGEMENT UNIT ONLY THESE COMPANIES PRODUCTS ARE COVERED AND ONLY THOSE DOSAGE FORMS LISTED IN APPENDIX A. MEDICAID DRUG FEDERAL REBATE PARTICIPATING PHARMACEUTICAL COMPANIES LABELER PHARMACEUTICAL COMPANY EFFECTIVE END DATE CODE DATE 00002 ELI LILLY & CO 04/01/91 00003 E.R.SQUIBB & SONS,INC 04/01/91 00004 HOFFMAN-LA ROCHE,INC 04/01/91 00005 LEDERLE LABORATORIES AMERICAN CYANAMID 04/01/91 00006 MERCK SHARP & DOHME 04/01/91 00007 SMITHKLINE BEECHAM CORPORATION 04/01/91 00008 WYETH LABORATORIES 04/01/91 00009 THE UPJOHN COMPANY 04/01/91 00011 BECTON DICKINSON MICROBIOLOGY SYSTEMS 10/01/91 07/01/98 00013 ADRIA LABORATORIES DIV.OF ERBAMONT,INC 04/01/91 00014 G.D.SEARLE & CO 04/01/91 01/01/01 00015 MEAD JOHNSON & COMPANY 04/01/91 00016 KABI PHARMACIA 04/01/91 00021 REED & CARNRICK 10/01/96 01/01/97 00023 ALLERGAN,INC 04/01/91 00024 WINTHROP PHARMACEUTICALS 04/01/91 00025 G.D.SEARLE & CO 04/01/91 00026 MILES INC.,PHARMACEUTICAL DIVISION 04/01/91 00028 GEIGY PHARMACEUTICALS 04/01/91 00029 SMITHKLINE BEECHAM CORPORATION 04/01/91 00031 ROBINS,A.H. 04/01/91 00032 SOLVAY PHARMACEUTICALS 04/01/91 00033 SYNTEX 04/01/91 00034 THE PURDUE FREDERICK COMPANY 04/01/91 00037 CARTER-WALLACE,INC 04/01/91 00038 STUART PHARMACEUTICALS,ICI AMERICAS INC 04/01/91 07/01/01 00039 HOECHST-ROUSSEL PHARMACEUTICALS INC 04/01/91 00043 SANDOZ CONSUMER CORPORATION 04/01/91 00044 KNOLL PHARMACEUTICALS
  • 25 Years of the Swiss Chemical Society's Division of Analytical

    25 Years of the Swiss Chemical Society's Division of Analytical

    Columns CHIMIA 2017, 71, No. 12 861 doi:10.2533/chimia.2017.861 Chimia 71 (2017) 861 © Swiss Chemical Society Division of Analytical Sciences A Division of the Swiss Chemical Society 1992–2017: 25 Years of the Swiss Chemical Society’s the fact that its scope is not limited to chemistry but also includes Division of Analytical Sciences – Past, Present and physical techniques and biological methods. Future Activities Walter Giger*, Fritz Erni, and Ernst Halder Membership – Organisation – Communication *Correspondence: Prof. W. Giger, CH-8049 Zurich, E-mail: [email protected] In 1996, almost 300 members of the Swiss Chemical Society were also members of the DAC. By 2017, membership had Keywords: Analytical Sciences · Division of Analytical Sciences increased to 585 (22% of Swiss Chemical Society members). Most of the DAC’s activities were managed and organised by Launch in the 1990s – Scope and Goals – Name therelativelylargeDAC Board,comprisingabout9to17members, several of whom were active for many years. Every other year, In the early 1990s, the chemists’ professional societies in the DAC Board held a retreat, where current endeavours were Switzerland were reorganised. The major event was the merger evaluated and future projects thoroughly discussed and planned. of the Swiss Chemical Society and the Association of Swiss In 1999, the importance of the internet for gaining visibility Chemists in spring 1992. Around the same time, the analytical and meeting members’ needs became evident. Ernst Halder chemists informally organised in the Comité Suisse de Chimie and Käthi Halder initiated and maintained a divisional website Analytique (see CHIMIA 1990, 44(9), 298–299) became the at www.sach.ch, including, most importantly, information on Analytical Chemistry Section (SACh) of the New Swiss Chemical the training programme.
  • Overview of Ftc Antitrust Actions in Pharmaceutical Services and Products

    Overview of Ftc Antitrust Actions in Pharmaceutical Services and Products

    OVERVIEW OF FTC ANTITRUST ACTIONS IN PHARMACEUTICAL SERVICES AND PRODUCTS Health Care Division Bureau of Competition Federal Trade Commission Washington D.C. 20580 Markus H. Meier Assistant Director Bradley S. Albert Deputy Assistant Director Saralisa C. Brau Deputy Assistant Director September 2009 TABLE OF CONTENTS Page I. INTRODUCTION. ........................................................... 1 II. CONDUCT INVOLVING PHARMACEUTICAL SERVICES AND PRODUCTS. 3 A. Monopolization. ...................................................... 3 B. Agreements Not to Compete. ............................................ 8 C. Agreements on Price or Price-Related Terms. 14 D. Agreements to Obstruct Innovative Forms of Health Care Delivery or Financing. 20 E. Illegal Tying and Other Arrangements. .................................... 20 III. PHARMACEUTICAL MERGERS. ........................................... 20 A. Horizontal Mergers Between Direct Competitors. 20 B. Potential Competition Mergers. ......................................... 44 C. Innovation Market Mergers. ............................................ 47 D. Vertical Mergers...................................................... 49 IV. INDUSTRY GUIDANCE STATEMENTS...................................... 50 A. Advisory Opinions. ................................................... 50 B. Citizen Petition to the Food and Drug Administration. 51 V. AMICUS BRIEFS. ......................................................... 51 VI. INDICES. ............................................................
  • Supply and Demand for Medicines Published in Scotland by the Scottish Parliamentary Corporate Body

    Supply and Demand for Medicines Published in Scotland by the Scottish Parliamentary Corporate Body

    Published 30 June 2020 SP Paper 774 6th Report, 2020 (Session 5) Health and Sport Committee Comataidh Slàinte is Spòrs Supply and demand for medicines Published in Scotland by the Scottish Parliamentary Corporate Body. All documents are available on the Scottish For information on the Scottish Parliament contact Parliament website at: Public Information on: http://www.parliament.scot/abouttheparliament/ Telephone: 0131 348 5000 91279.aspx Textphone: 0800 092 7100 Email: [email protected] © Parliamentary copyright. Scottish Parliament Corporate Body The Scottish Parliament's copyright policy can be found on the website — www.parliament.scot Health and Sport Committee Supply and demand for medicines, 6th Report, 2020 (Session 5) Contents Executive Summary _____________________________________________________1 Introduction ____________________________________________________________4 Engagement___________________________________________________________4 Structure of the report ___________________________________________________5 Background ___________________________________________________________6 Research and development _______________________________________________8 Real-world experience and clinical trials _____________________________________8 Personalised medicine___________________________________________________9 Waste _____________________________________________________________10 Manufacturing technology _____________________________________________10 Preparedness for personalised medicine in the healthcare system ______________10
  • Coordination Des Syndicats CGT

    Coordination Des Syndicats CGT

    Coordination des syndicats CGT STRATEGIE DE LA DIRECTION DU GROUPE SANOFI CONSEQUENCES INDUSTRIELLES ET SOCIALES Document d’août 2014 1. Situation économique – Coût du capital p2 2. Evolution des effectifs – Bilan des restructurations majeures p3 3. Stratégie Sanofi 2009-2015 : Désengagement scientifique et industriel en Europe et plus particulièrement en France p4 4. Stratégie de structuration du groupe en entités qui peuvent être cédées, vendues, fermées, échangées. p6 5. Crédit d’impôt – Des aides publiques pour quel usage ? p7 6. Industrie pharmaceutique : des besoins fondamentaux p7 7. Interpellation des élus et du gouvernement p8 1. Situation économique – Coût du capital Première entreprise pharmaceutique française et européenne. Sanofi est issu de la fusion de nombreux laboratoires pharmaceutiques français dont les principaux étaient Roussel Uclaf, Rhône Poulenc, Synthelabo, Sanofi et de l’allemand Hoechst. Sanofi représente 30 à 40% du potentiel national (effectifs, sites, R&D,…) de l’industrie pharmaceutique française dans notre pays. L’avenir du groupe et de ses activités en France conditionne l’avenir de l’industrie pharmaceutique française et constitue un élément incontournable de l’indépendance thérapeutique du pays. Le C.A. de sanofi dans le monde sur 2013 a atteint 33 milliards € et devrait se situer à un niveau légèrement supérieur en 2014. Plusieurs médicaments de référence étant aujourd’hui tombés dans le domaine public, le chiffre d’affaires repart à la hausse. Le résultat net des activités a été de 6,8 milliards € en 2013 et les projections sur 2014 laissent envisager une progression de 5% de celui-ci. La rentabilité est estimée par les économistes parmi les meilleures de l’industrie pharmaceutique dans le monde.
  • September 24, 2008 (Download PDF)

    September 24, 2008 (Download PDF)

    Volume 53, Number 3 TechTalk Wednesday, September 24, 2008 S ERVING THE MIT CO mm UNI T Y 1 2 3 4 5 6 7 of the Mass. Ave. Bridge RULERLength : 2,164.8 feet (or 364.4 Smoots ± an ear) SMOOT ANNIVERSARY EVENTS: Oct. 4 Smoot reflects on his measurement Charles River clean up 11:30 a.m.-4 p.m. feat as 50th anniversary nears Volunteers from the MIT community and beyond gather at the Kresge Oval for a barbecue lunch before cleaning the shoreline of the Patrick Gillooly Charles River. MIT President Susan Hockfield, Oliver Smoot and other News Office guests will speak at 12:30 p.m. Visit web.mit.edu/smoot/schedule.htm to s his fraternity brothers laid his 5-foot, 7-inch frame end- register. to-end to measure the Massachusetts Avenue bridge one Herb Reed and the Platters Concert 5-6:30 p.m. Anight in October 1958, there was one distinct thought running through Oliver Smoot’s mind. Famed ’50s music group Herb Reed and the Platters play the MIT “It was pretty cold,” he said. Kresge Auditorium at 5 p.m. Pre-show tickets available for $25 online at Smoot ’62 evoked memories recently about the night his web.mit.edu/smoot/platters.htm; tickets at the door (if available) $35. name became a unit of measurement as MIT prepares to cele- brate the 50th anniversary of the quirky MIT Big ’50s Party 6:30-11 p.m. hack. A series of events has been planned The MIT Club of Boston, the Class of 1962 and Lambda Chi See web.mit.edu/ for the weekend of Oct.
  • National Lipid Association Annual Summary of Clinical Lipidology 2016 Disclosures Dr. Harold E. Bays: Dr. Bays Discloses That He

    National Lipid Association Annual Summary of Clinical Lipidology 2016 Disclosures Dr. Harold E. Bays: Dr. Bays Discloses That He

    National Lipid Association Annual Summary of Clinical Lipidology 2016 Disclosures Dr. Harold E. Bays: Dr. Bays discloses that he has received research grants from Arena Pharmaceuticals, Boehringer Ingelheim, Cargill Inc., GlaxoSmithKline, Novo Nordisk, Orexigen Therapeutics, Shionogi, Takeda, Stratum Nutrition, California Raisin Board, Esperion, Essentialis, Forest, Gilead Sciences Inc., Given, Hoffman-LaRoche, Home Access, Novartis, Omthera, Pfizer, Trygg Pharmaceuticals, TWI Bio, Xoma, Ardea Inc., High Point Pharmaceuticals LLC, Micropharma Limited, TransTech Pharma Inc., TIMI, Pozen, Regeneron, and Elcelyx. He further discloses that he has received honoraria/research grants from Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Catabasis, Daiichi-Sankyo Inc., Eisai, Merck & Co, VIVUS, Zeomedex, and WPU. Dr. Peter H. Jones: Dr. Jones has received consulting or speaker honoraria from Merck and Co., Amgen, and Sanofi-Aventis/Regeneron. Dr. W. Virgil Brown: Dr. Brown is the editor of the Journal of Clinical Lipidology and further discloses that he has received consulting fees/honoraria from Akcea, Esperion, Regeneron, Amgen, Genzyme, Pfizer Inc., Merck and Co, GlaxoSmithKline, Medtelligence, and Vindico. Dr. Terry A. Jacobson: Dr. Jacobson has received consulting fees from Merck and Co., Amarin, Amgen, AstraZeneca, and Regeneron/Sanofi-Aventis. Dr. Karen E. Aspry: Dr. Aspry has no disclosures to report. Dr. Christie M. Ballantyne: Dr. Ballantyne has received research grants from Abbott Diagnostics, Amarin, Amgen, Eli Lilly, Esperion, ISIS Pharmaceuticals, Novartis Pharmaceuticals, Pfizer, Otsuka, Regeneron, Roche Diagnostic, Sanofi-Synthelabo, and Takeda Pharmaceuticals. He has also received consulting fees from Abbott Diagnostics, Amarin, Amgen, AstraZeneca, Eli Lilly, Esperion, Genzyme, ISIS Pharmaceuticals, Matinas BioPharma Inc., Merck and Co., Novartis Pharmaceuticals, Pfizer, Regeneron, Roche, and Sanofi-Synthelabo.